Organization | Vimta Labs Ltd.

Vimta Labs Ltd. Report issue

For profit Phase 1 Phase 3

Founded: Hyderabad India (1984)

Status: No NME R&D (1984)

Organization Overview

First Clinical Trial

2004

NCT01283932

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Alternative names

Vimta Labs Limited, 142, IDA, Phase-II, Cherlapally, Hyderabad - India-500 051 | Vimta Labs Limited, 142, IDA, Phase-II, Cherlapally, Hyderabad, India-500 051 | Vimta Labs Limited, Hyderabad, India, 500 051 | Vimta Labs Ltd., | VimtaLabsLtd. | Vimta VHS Research Centre

Active Ingredients

Drugs in Phase 3 Trials (1)

ondansetron (zofran) (4 trials)

Drugs in Phase 1 Trials (8)

amlodipine (norvasc) (2 trials)

atorvastatin (lipitor) (1 trial)

benazepril (lotensin) (2 trials)

levocetirizine (xyzal) (2 trials)

omeprazole (prilosec) (3 trials)

pantoprazole (protonix) (2 trials)

simvastatin (zocor) (2 trials)

sitagliptin (januvia) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malnutrition (Phase 1)

Overview

Highest Phase: Phase 3
# of Trials: 18
# of Trial APIs: 9